Navigation Links
MUHC researchers make cancer target breakthrough

Researchers at the McGill University Health Centre (MUHC), in Montreal, have identified a new gene to combat cancer. In a new study, published in the on-line edition of the journal Clinical Cancer Research this week, the researchers document a reduction in the growth of both colon and lung cancer tumors with inhibition of the gene.

The new target gene is called methylenetetrahydrofolate reductase, or MTHFR. Researchers were able to inhibit the function of the gene by creating antisense--an exact opposite of a tiny section of the MTHFR gene. "MTHFR is involved in the synthesis of methionine--a critical nutrient necessary for growth of cancer cells," explains Dr. Rima Rozen, principal investigator of the new study, and Deputy Scientific Director of the MUHC Research Institute. "By inhibiting the gene's function, we were able to slow the growth of tumors."

Researchers found that the antisense reduced lung and colon cancer tumors in both laboratory-based tissue cultures and in mice. "Discovering that the antisense works in animal models is a major step forward, and gives us hope that this might also work in humans," explains Dr. Rozen.

The research, funded by Strida Pharma--a McGill University spin-off company--also indicated that the antisense was particularly effective in reducing cancer tumors when administered in low doses and in combination with established cancer drugs. "All drugs and antisense have some level of toxicity," says Dr. Rozen. "An antisense that works in harmony with other drugs, and in such low doses, is a significant breakthrough in cancer research."


'"/>

Source:McGill University


Page: 1

Related biology news :

1. NYU researchers simulate molecular biological clock
2. Vital step in cellular migration described by UCSD medical researchers
3. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
4. UCSD researchers maintain stem cells without contaminated animal feeder layers
5. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
6. New protein discovered by Hebrew University researchers
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Agilent Technologies releases automated literature search tool for biology researchers
9. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. US life expectancy about to decline, researchers say

Post Your Comments:
(Date:11/4/2009)...-FirstCall/ -- BIO-key International, Inc. (OTC Bu...etric identification software is showcasing donor ...nference being held at the New Orleans Convention ...de hands-on product demonstrations of its state-of...Also, at 5 PM on Monday, October 26, Peter Lux, ma...
(Date:11/4/2009)... Glencoe Software, Inc., the commercial arm of the...ttp://openmicroscopy.org ), is proud to announce ...l Biology,s exciting new project titled "The Cell:....5M stimulus grant through the National Institutes... part of the American Reinvestment and Recovery Ac...
(Date:11/3/2009)...rt published in a recent issue of HortTechnology ...ed the effects of covering orchard floors with ref...y light distribution, orchard temperature, and pro...xtenday and Solarmate films installed 5 weeks befo..., apples. The research showed that the use of both...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2Cepheid Reports 2009 Second Quarter Results 53277 1Cepheid Reports 2009 Second Quarter Results 53277 2Cepheid Reports 2009 Second Quarter Results 53277 3Cepheid Reports 2009 Second Quarter Results 53277 4Cepheid Reports 2009 Second Quarter Results 53277 5Cepheid Reports 2009 Second Quarter Results 53277 6Cepheid Reports 2009 Second Quarter Results 53277 7Cepheid Reports 2009 Second Quarter Results 53277 8Cepheid Reports 2009 Second Quarter Results 53277 9Cepheid Reports 2009 Second Quarter Results 53277 10Cepheid Reports 2009 Second Quarter Results 53277 11Cepheid Reports 2009 Second Quarter Results 53277 12Cepheid Reports 2009 Second Quarter Results 53277 13Cepheid Reports 2009 Second Quarter Results 53277 14Cepheid Reports 2009 Second Quarter Results 53277 15Cepheid Reports 2009 Second Quarter Results 53277 16Cepheid Reports 2009 Second Quarter Results 53277 17Cepheid Reports 2009 Second Quarter Results 53277 18Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 1Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call 13296 2Flu Shot May Be Less Effective in Those With Lupus 53274 1Flu Shot May Be Less Effective in Those With Lupus 53274 2
...lease is also available in Spanish . , Barcelo... number of times women undergo assisted reproducti...the overwhelming majority achieve a pregnancy with...age of 40 had a more consistent, but lower, pregna...attempts. , Mr Simon Hong told the 24th annual m...
...e current drive towards production of alternative ... down this material into useable compounds are req... One group of scientists from Texas A&M University...e the enzymes. Professor Zivko Nikolov, who leads...rch on Monday 7th July at the Society for Experime...
...STATION, July 7, 2008 A study published in the cu...belief that diversity of marine species has been i.... Dr. Thomas D. Olszewski, a geology and geophysic...rt of the international team that carried out this...he diversification occurred early on relatively s...
Other Biology News:Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 2Failure of the 1st attempt at assisted reproduction justifies at least 1 additional cycle 3A green solution to biofuel production 2Setting the record right: species diversity less dramatic than previously believed 2
(Date:11/5/2009)...PRNewswire/ -- DSM Pharmaceutical Products today a... with Galenix, Saint Jean D,Illac, France, where D...uring partner for Galenix commercial products on a...ate on business development opportunities co-marke...the strength of Galenix in drug product developmen...
(Date:11/5/2009)...Newswire-FirstCall/ -- BioSpecifics Technologies C... developing first-in-class collagenase-based produ... third quarter ended September 30, 2009. ,, "W...year, the FDA,s Arthritis Advisory Committee unani...l of XIAFLEX(TM) for the treatment of Dupuytren,s ...
(Date:11/5/2009)...ewswire/ -- SpineSmith Partners has signed an init...unique scaffold that mimics the structure of natur...al commercial products by SpineSmith,s Research an... GenOsteo scaffold represents a significant advanc...l environment for the delivery of adult stem cells...
(Date:11/4/2009)...ebinar, which will be presented on November 19 and...ow chemistry processing, will deal with the applic...s meso and micro scale flow chemistry equipment. ...been recognized with several prestigious prizes an...dron Prize. , Columbia, M...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...ation,(Nasdaq: CRGN ), a clinical-stage biopharma...ced that it received a letter, dated January 28,20...n that during the,preceding 30 consecutive trading...tock has been below the $1.00 minimum bid per shar...bal Market under NASDAQ Marketplace Rule,4450(a)(5...
...cientific Inc. (NYSE: TMO ), the world leader in ... the 2008 Merrill Lynch Global Pharmaceutical,Biot...t the Grand Hyatt,Hotel in New York City. The comp...9:20 am (EST)., Marijn E. Dekkers, president and ...c, will provide an overview of the company and dis...
...iences, Inc. (Nasdaq: SGMO ) today announced that...ear-end 2007 financial results on Tuesday,February...se will be,followed by a conference call at 2:00 p...hone and webcast. During the conference call, the ...uss other business matters., The conference call ...
Other Biology Technology:CuraGen Corporation Receives Notification from NASDAQ 2CuraGen Corporation Receives Notification from NASDAQ 3Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast 3
The Protein Kinase Factsbooks (2 Volume Set) from Promega
...ning Kit, 1. Select from homogeneous and gradient ... on denaturing, native, and isoelectric focusing g...cast gels, buffer strips, and staining kits.Achiev...oisotopes with ready-to-use silver staining kits. ...
Mouse Anti-STAPHYLOCOCCUS ENTEROTOXIN B (+C2, +D) Monoclonal Antibody, Unconjugated, Clone S5 from AbD Serotec
Porcine Serum from Lifeblood Medical, Inc.
Biology Products: